Specialised compounding - Practices and opinions of Australian community pharmacists

Journal of Pharmacy Practice and Research

Volumn 37, Issue 4, 2007, Pages 260-264

  Giam, Jennifer A ^a   McLachlan, Andrew J ^a   Krass, Ines ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANALYTIC METHOD; ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; DRUG DOSAGE FORM; FEMALE; HUMAN; MALE; MEDICAL SPECIALIST; NORMAL HUMAN; PHARMACIST; PRACTICE GUIDELINE; PRESCRIPTION; QUESTIONNAIRE;

EID: 39449112456     PISSN: 1445937X     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.2055-2335.2007.tb00761.x     Document Type: Article

References (22)

1. Slezak M. The roots of modern pharmacy practice. Am Drug 1996; 32-64.
2. Buurma H, de Smet PA, van den Hoff OP, Sysling H, Storimans M, Egberts AC. Frequency, nature and determinants of pharmacy compounded medicines in Dutch community pharmacies. Pharm World Sci 2003; 25: 280-7.
3. Food and Drug Administration. Federal and state role in pharmacy compounding and reconstitution: exploring the right mix to protect patients. Rockville: FDA; 2003.
4. Pharmacy Board of New South Wales. Code of conduct for extemporaneous compounding of medicines. Surry Hills: Pharmacy Board of NSW; 2002.
5. Pharmacy Board of Victoria. Specialised extemporaneous dispensing. Pharmacy Board of Victoria Circular 2003. p. 3-5.
6. Pharmacists Board of Queensland. Compounding. Bulletin 2003; 18.
7. Therapeutic Goods Administration. Review of the need for further regulation of extemporaneous compounding. Canberra: TGA; 2005. Available from 〈www.tga.gov.au/meds/extempcomp.htm〉. Accessed 5 November 2005.
8. Medicare Australia. 2003/2004 Financial year report. Canberra: Medicare Australia; 2004. Available from 〈www.medicareaustralia.gov.au/about/ about_us/annual_report/03_04/index.shtml〉. Accessed 17 April 2007.
9. Drug Utilisation Sub-Committee. Australian statistics on medicines 2001-2002. Canberra: DUSC; 2002. p. 7, 29.
10. General Practice Research Network. HCN Research Division. 2006. Available from 〈www.hcn.net.au/doctors/gprn.asp〉. Accessed 21 February 2006.
11. Britt H, Miller GC, Knox S, Charles J, Valenti L, Pan Y, et al. General practice activity in Australia 2003-04. Canberra: Australian Institute of Health and Welfare (General Practice Series No. 16); 2004.
12. Giam JA, McLachlan AJ. Quantifying extemporaneous dispensing in Australia. Where is the evidence [abstract]? National Prescribing Symposium. Canberra: NPS; 2006. p. 64.
13. Berbatis C, Sunderland VB, Mills C, Bulsara M. National pharmacy database project. Perth: Curtin University of Technology; 2003. Available from 〈www.guild.org.au/uploadedfiles/Research_and_Development_Grants_Program/ Projects/2001-056_fr.pdf〉. Accessed 17 June 2005.
14. Dunphy D, Palmer I, Benrimoj SI, Roberts A. Change management and community pharmacy project. Sydney: University of Technology; 2005. Available from 〈www.guild.org.au/uploadedfiles/ Research_and_Development_Grants_Program/Projects/2003-530_fr1.pdf〉. Accessed 11 April 2005.
15. Pappas A. Extemporaneous dispensing: opinions of Victorian community pharmacists. Aust J Hosp Pharm 1999; 29: 196-201.
16. McPherson T, Fontane P, Jackson K, Martin K, Berry T, Chereson R, et al. Prevalence of compounding in independent community pharmacy practice. J Am Pharm Assoc 2007; 46: 568-73.
17. Pharmacy Guild of Australia. Australian pharmacies - comparison between 2004 and 2005. Canberra: PGA; 2005. Available from 〈beta.guild.org.au/ uploadedfiles/National/Member_Only/Business_Issues_and_Benchmarking/ Guild_Digest/dig06table2.pdf〉. Accessed 15 April 2007.
18. Therapeutic Goods Administration. Meeting report with stakeholders on extemporaneous compounding. Canberra: TGA; 2006.
19. US Pharmacopeial Convention. Pharmacy compounding. US Pharmacopeia 28 and National Formulary 23. Washington: US Pharmacopeial Convention Inc; 2004. p. 2457-60.
20. US Pharmacopeial Convention. Pharmaceutical compounding - sterile preparations. US Pharmacopeia 28 and National Formulary 23. Washington: US Pharmacopeial Convention Inc; 2004. p. 2461-77.
21. British Pharmacopoeia Commission. Supplementary chapter V unlicensed medicines. British Pharmacopoeia. Vol. IV. London: Stationery Office; 2007.
22. Kettis Lindblad A, Isacson D, Sörbom D. Pharmacists' attitudes towards the importance of compounding to their profession. J Soc Adm Pharm 2000; 17: 143-50.